LAMZEDE Israel - engelska - Ministry of Health

lamzede

kamada ltd, israel - velmanase alfa - powder for solution for infusion - velmanase alfa 10 mg/vial - velmanase alfa - enzyme replacement therapy for the treatment of non-neurological manifestations in patients with mild to moderate alpha mannosidosis.

ZENALB 4.5 Israel - engelska - Ministry of Health

zenalb 4.5

kamada ltd, israel - albumin human - solution for infusion - albumin human 45 mg/ml - albumin - albumin - for restoration and maintenance of circulation blood volume where volume deficiency has been demonstrated and use of a colloid, is appropriate.

ALBIOMIN 20 % Israel - engelska - Ministry of Health

albiomin 20 %

kamada ltd, israel - plasma protein fraction - solution for infusion - plasma protein fraction 200 mg/ml - protein c - protein c - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendation.

INTRATECT 50 GL Israel - engelska - Ministry of Health

intratect 50 gl

kamada ltd, israel - human normal immunoglobulin - solution for infusion - human normal immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in adults, and children and adolescents (0-18 years) in:- primary immunodeficiency syndromes (pid) with impaired antibody production- secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of <4 g/l* psaf= failure to mount at least a 2-fold rise in igg antibody titre to pneumococcal polysaccharide and polypeptide antigen vaccinesimmunomodulation in adults, and children and adolescents (0-18 years) in:- primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count- guillain barré syndrome- kawasaki disease (in conjunction with acetylsalicylic acid)- chronic inflammatory demyelinating polyradiculoneuropathy (cidp)- multifocal motor neuropathy (mmn)

HEPARIN EP, LOCK FLUSH SOLUTION 100 IU/ML Israel - engelska - Ministry of Health

heparin ep, lock flush solution 100 iu/ml

kamada ltd - heparin as sodium 100 iu/ml - solution for injection - heparin - to maintain patency of an indwelling intravenous catheter designed for intermittent injection or blood sampling.

HEPARIN EP, LOCK FLUSH SOLUTION 10 IU/ML Israel - engelska - Ministry of Health

heparin ep, lock flush solution 10 iu/ml

kamada ltd - heparin as sodium 10 iu/ml - solution for injection - heparin - intended to maintain potency of indweling i.v. catheter designed for intermittent injection therapy of blood sampling. may be used following initial placement of the device in the vein, an injection of a medication or after withdrawal of blood for laboratory analysis.

PROTOSOL Israel - engelska - Ministry of Health

protosol

kamada ltd - aprotinin 10000 kiu / 1 ml - solution for injection - aprotinin - protosol is used in adults in the treatment and prophylaxis of disorders in which inhibition of proteolytic enzymes is indicated: for the early treatment of states of shock. for the prevention of postoperative or post-traumatic complications. to reduce major blood loss in patients undergoing surgery involving cardiopulmonary bypass.

KAMACAINE 0.5 % USP INJECTION Israel - engelska - Ministry of Health

kamacaine 0.5 % usp injection

kamada ltd - bupivacaine hydrochloride 100 mg / 20 ml - solution for injection - bupivacaine - kamacaine is indicated for the production of local or regional anesthesia or analgesia for surgery, oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. kamacaine is also indicated for spinal anesthesia for surgery.

ELIGARD 22.5 MG Israel - engelska - Ministry of Health

eligard 22.5 mg

kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 22.5 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

ELIGARD 45 MG Israel - engelska - Ministry of Health

eligard 45 mg

kamada ltd, israel - leuprorelin acetate - powder and solvent for solution for injection - leuprorelin acetate 45 mg - eligard is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localized and locally advanced hormone dependent prostate cancer in combination with radiotherapy.